ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,838Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 807

$518K Total Retail Price of All Prescriptions

Rank: 104 out of 807

613 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 613 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 11,913 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 977 852 1 2
LEVOTHYROXINE SODIUM 755 664 2 3
AMLODIPINE BESYLATE 734 690 3 5
LOVASTATIN 557 447 4 39
OMEPRAZOLE 545 405 5 4
SIMVASTATIN 534 442 6 1
ATENOLOL 456 405 7 7
HYDROCHLOROTHIAZIDE 430 407 8 9
METOPROLOL TARTRATE 411 352 9 8
CITALOPRAM HBR 382 264 10 17
METFORMIN HCL 354 258 11 12
FUROSEMIDE 288 250 12 6
HYDROCODONE-ACETAMINOPHEN 272 185 S3 13 15
GABAPENTIN 265 195 14 16
WARFARIN SODIUM 231 205 15 10
METOPROLOL SUCCINATE 220 176 16 13
TRAZODONE HCL 203 156 17 25
ATORVASTATIN CALCIUM 195 168 18 11
RANITIDINE HCL 194 110 19 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 160 20 28
PRAVASTATIN SODIUM 186 164 21 21
SERTRALINE HCL 166 154 22 22
LOSARTAN POTASSIUM 160 136 23 14
ALLOPURINOL 140 110 24 26
CYCLOBENZAPRINE HCL 126 65 R 25 88
QUINAPRIL HCL 124 122 26 199
OXYCODONE HCL 124 67 S2 26 53
SPIRIVA 119 94 28 50
FLUOXETINE HCL 117 59 29 52
PROAIR HFA 113 60 30 43
POTASSIUM CHLORIDE 111 96 31 18
CARVEDILOL 110 92 32 35
CLOPIDOGREL 109 95 33 47
CYMBALTA 106 61 34 73
ALENDRONATE SODIUM 104 104 35 20
ADVAIR DISKUS 101 53 36 33
OXYBUTYNIN CHLORIDE 98 85 37 108
TRAMADOL HCL 86 52 38 19
DOXAZOSIN MESYLATE 81 74 39 70
JANTOVEN 81 81 39 37
DONEPEZIL HCL 79 63 41 31
MIRTAZAPINE 77 56 42 38
CHLORTHALIDONE 75 70 43 99
NIFEDIPINE ER 74 74 44 163
GEMFIBROZIL 73 53 45 74
CRESTOR 72 54 46 32
PLAVIX 72 63 46 60
PAROXETINE HCL 70 60 48 49
GLIMEPIRIDE 68 50 49 51
PANTOPRAZOLE SODIUM 68 57 49 44
BENICAR 63 58 51 237
DIOVAN 63 63 51 46
POLYETHYLENE GLYCOL 3350 57 48 53 40
CARBIDOPA-LEVODOPA 57 57 53 64
LORATADINE 55 13 55 207
BUSPIRONE HCL 54 42 56 160
TRIAMCINOLONE ACETONIDE 53 39 57 98
NAPROXEN 52 33 58 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.